
Burjeel to Repurchase 10% of Its Share Capital
Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region and listed on the Abu Dhabi Securities Exchange (ADX), is exploring a share buyback program of up to 10% of the Group’s share capital, subject to regulatory approval from shareholders and the UAE’s Securities and Commodities Authority (SCA).
This initiative reflects the Board’s confidence in the Group’s significant growth potential over the mid and long term. The share buyback program aligns with Burjeel Holdings’ commitment to optimising capital structure and enhancing shareholder value, Burjeel Holdings said in a regulatory disclosure with ADX last night.
The Group remains on track for mid-teens revenue growth and EBITDA margin expansion in 2025 and beyond, driven by the accelerated ramp-up of high-growth assets, expansion of high-complexity procedures, and ongoing cost optimisation initiatives. As a result, profit before tax is expected to grow at approximately 25% CAGR over the next four years.
Burjeel Holdings continues to strengthen its position as a leading healthcare provider by investing in dvanced medical technologies, expanding its portfolio of specialty services, and enhancing patient care delivery.
The Group remains focused on driving operational efficiencies, broadening its service offerings, and leveraging digital transformation to maximize long-term stakeholder value.
Buyback Program Details
Upon approval from shareholders and regulators, Burjeel Holdings intends to execute a share buyback program of up to 10% of the Group’s share capital, to be conducted through open market purchases.
This initiative will be fully funded through the Group’s operating cash flow, reflecting its strong financial position.
Following the buyback program, the management is evaluating various options for utilising the repurchased shares, including potential re-sale based on market conditions, allocation to long-term incentive (LTI) plans, or other regulator-approved strategies that support broader capital management objectives.
Burjeel Holdings CEO John Sunil said that the company is well-positioned to achieve its ambitious growth targets, in line with the strategic guidance provided to the market.
“With our strong operational performance and favourable market trends, we believe the Group’s intrinsic value is not yet fully reflected in its current market valuation. Recognising this opportunity, we proactively sought Board of Directors’ approval to explore a share buyback initiative,” he said.
With this mandate secured, the company will work closely with regulators and shareholders to finalise the buyback program and ensure timely market updates upon receiving the necessary approvals, he added.